Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 2026 entries
View as:

An Observational Study of Rituximab in Combination With Methotrexate in Participants With Active Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01283399 Org: User:
Start: 08/31/10 End: 04/30/14 Due: 04/30/15

A Pharmacokinetic Study of CellCept (Mycophenolate Mofetil) Versus Mycophenolate Sodium in Kidney Transplant Patients

Phase: N/A Priority: Normal
NCT ID: NCT01033864 Org: User:
Start: 11/30/09 End: 06/30/10 Due: 06/30/11

Non-Interventional Study of Tocilizumab Subcutaneous (SC) Monotherapy in Participants With Rheumatoid Arthritis (RA)

Phase: N/A Priority: Normal
NCT ID: NCT02402686 Org: User:
Start: 05/20/15 End: 12/17/18 Due: 12/17/19

A Study of Intravenous (IV) Cergutuzumab Amunaleukin and Atezolizumab in Combination in Participants With Locally Advanced and/or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02350673 Org: User:
Start: 06/29/15 End: 12/16/19 Due: 12/16/20

A Relative Bioavailability Study of Setrobuvir Tablet Formulation Versus Reference Setrobuvir Capsule Formulation in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01612143 Org: User:
Start: 06/30/12 End: 09/30/12 Due: 09/30/13

A Study of The Effect of Aleglitazar on Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin

Phase: N/A Priority: Normal
NCT ID: NCT01729403 Org: User:
Start: 12/31/12 End: 09/30/13 Due: 09/30/14

A Study on Safety and Efficacy of Tocilizumab (RoActemra/Actemra) Alone or in Combination With Non-Biologic Antirheumatics in Participants With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01987479 Org: User:
Start: 01/30/14 End: 05/26/16 Due: 05/26/17

A Study of Avastin (Bevacizumab) in Combination With Standard Therapy in Patients With Metastatic Renal Cell Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT00520403 Org: User:
Start: 09/30/07 End: 03/31/10 Due: 03/31/11

Safety, Tolerability, and Antiviral Activity of ANA598 Administered in Combination With Pegylated Interferon and Ribavirin for the Treatment of Genotype-1 Chronic HCV Infection

Phase: N/A Priority: Normal
NCT ID: NCT00978497 Org: User:
Start: 09/30/09 End: 08/31/11 Due: 08/31/12

A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.

Phase: N/A Priority: Normal
NCT ID: NCT00366379 Org: User:
Start: 07/31/06 End: 06/30/07 Due: 06/30/08

An Observational Study of Dosage Patterns in Routine Clinical Practice in Patients With Rheumatoid Arthritis (ACT-LIFE)

Phase: N/A Priority: Normal
NCT ID: NCT01338545 Org: User:
Start: 07/31/10 End: 09/30/12 Due: 09/30/13

A Clinical Trial to Evaluate Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants Without Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT02847637 Org: User:
Start: 09/27/16 End: 05/12/22 Due: 05/12/23

AVAdeno Study: An Observational Study of First-Line Avastin (Bevacizumab) in Patients With Adenocarcinoma of the Lung

Phase: N/A Priority: Normal
NCT ID: NCT01827852 Org: User:
Start: 03/14/13 End: 05/31/17 Due: 05/31/18

A Study of Mircera (C.E.R.A.) in Patients With Pre-Dialysis Chronic Renal Anemia

Phase: N/A Priority: Normal
NCT ID: NCT01342640 Org: User:
Start: 07/18/11 End: 11/30/12 Due: 11/30/13

A Study to Evaluate the Safety and Efficacy of Basmisanil in Adults With Severe Motor Impairment Following an Ischemic Stroke

Phase: N/A Priority: Normal
NCT ID: NCT02928393 Org: User:
Start: 02/20/17 End: 11/03/17 Due: 11/03/18

A Non-Interventional Study of the Occurrence Rate of Non-Small Cell Lung Cancer, Colon Cancer, Breast Cancer, Gastric Cancer and Malignant Melanoma in Turkey, and Diagnosis and Treatment Characteristics

Phase: N/A Priority: Normal
NCT ID: NCT01775514 Org: User:
Start: 10/31/12 End: 10/31/15 Due: 10/31/16

A Study of Xeloda (Capecitabine) in Breast Cancer Patients With Central Nervous System (CNS) Progression

Phase: N/A Priority: Normal
NCT ID: NCT01077726 Org: User:
Start: 01/31/10 End: 12/31/10 Due: 12/31/11

A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) as Maintenance Treatment in Patients With Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00623805 Org: User:
Start: 03/31/08 End: 05/31/12 Due: 05/31/13

HELENA Study: An Observational Study of Perjeta (Pertuzumab) in First-Line Treatment in Patients With Her2-Positive Advanced Breast Cancer After Adjuvant Herceptin Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01777958 Org: User:
Start: 06/14/13 End: 11/25/20 Due: 11/25/21

A Phase 1 Clinical Study in Healthy Volunteers to Investigate the Drug-drug Interaction Between Multiple Doses of RO7033877 and Multiple Doses of Colistin Methanesulfonate Sodium (CMS)

Phase: N/A Priority: Normal
NCT ID: NCT02156323 Org: User:
Start: 07/31/14 End: 03/31/15 Due: 03/31/16

A Study of Cobimetinib Plus Paclitaxel, Cobimetinib Plus Atezolizumab Plus Paclitaxel, or Cobimetinib Plus Atezolizumab Plus Nab-Paclitaxel as Initial Treatment for Participants With Triple-Negative Breast Cancer That Has Spread

Phase: N/A Priority: Normal
NCT ID: NCT02322814 Org: User:
Start: 03/12/15 End: 09/17/21 Due: 09/17/22

Comparison of In-House Methods and Cobas BRAF V600 Mutation Assay in Melanoma Tumor Samples

Phase: N/A Priority: Normal
NCT ID: NCT01744860 Org: User:
Start: 12/31/12 End: 04/30/13 Due: 04/30/14

A Study on The Safety of Administering Rituximab at A More Rapid Rate in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01382940 Org: User:
Start: 07/26/11 End: 01/06/13 Due: 01/06/14

A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.

Phase: N/A Priority: Normal
NCT ID: NCT00077623 Org: User:
Start: 03/31/04 End: 09/30/05 Due: 09/30/06

A Study of Dipeptidyl-peptidase IV (DPP-IV) RO4876904 in Patients With Type 2 Diabetes.

Phase: N/A Priority: Normal
NCT ID: NCT00502710 Org: User:
Start: 07/31/07 End: 04/30/08 Due: 04/30/09